- Home
- USIO vs MDAI Comparison
USIO vs MDAI Comparison
Compare USIO & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USIO
- MDAI
- Stock Information
- Founded
- USIO 1998
- MDAI 2013
- Country
- USIO United States
- MDAI United States
- Employees
- USIO N/A
- MDAI N/A
- Industry
- USIO Investment Bankers/Brokers/Service
- MDAI Medical/Dental Instruments
- Sector
- USIO Finance
- MDAI Health Care
- Exchange
- USIO Nasdaq
- MDAI Nasdaq
- Market Cap
- USIO 38.3M
- MDAI 34.8M
- IPO Year
- USIO N/A
- MDAI N/A
- Fundamental
- Price
- USIO $1.42
- MDAI $1.65
- Analyst Decision
- USIO Strong Buy
- MDAI Strong Buy
- Analyst Count
- USIO 2
- MDAI 2
- Target Price
- USIO $5.00
- MDAI $4.75
- AVG Volume (30 Days)
- USIO 69.9K
- MDAI 271.9K
- Earning Date
- USIO 05-14-2025
- MDAI 05-13-2025
- Dividend Yield
- USIO N/A
- MDAI N/A
- EPS Growth
- USIO N/A
- MDAI N/A
- EPS
- USIO 0.12
- MDAI N/A
- Revenue
- USIO $83,970,504.00
- MDAI $29,962,000.00
- Revenue This Year
- USIO $16.14
- MDAI N/A
- Revenue Next Year
- USIO $13.51
- MDAI $86.26
- P/E Ratio
- USIO $11.79
- MDAI N/A
- Revenue Growth
- USIO 0.46
- MDAI 55.21
- 52 Week Low
- USIO $1.24
- MDAI $0.82
- 52 Week High
- USIO $2.92
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- USIO 42.44
- MDAI 66.58
- Support Level
- USIO $1.39
- MDAI $1.57
- Resistance Level
- USIO $1.49
- MDAI $1.73
- Average True Range (ATR)
- USIO 0.06
- MDAI 0.09
- MACD
- USIO -0.01
- MDAI 0.04
- Stochastic Oscillator
- USIO 26.77
- MDAI 82.61
About USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.